Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Pacific Biosciences of California, Inc. (NASDAQ: PACB).

Full DD Report for PACB

You must become a subscriber to view this report.


Recent News from (NASDAQ: PACB)

Consolidated Research: 2018 Summary Expectations for Pacific Biosciences of California, NXP Semiconductors N.V., Consolidated Communications, Alexander & Baldwin, Willdan Group, and OneMain - Fundamental Analysis, Key Performance Indications
NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Pacific Biosciences of California, Inc. (NASDAQ:PACB), NXP Semiconductors...
Source: GlobeNewswire
Date: November, 07 2018 07:45
Best Performing Stocks YTD 2018
There are 66 stocks in the Russell 3,000 that are up more than 100% year-to-date in 2018. Below is a list of the 40 best performers. As shown, three stocks - NII Holdings (NIHD), Tandem Diabetes (TNDM), and Turtle Beach (HEAR) - are up 1,000%+ year-to-date, meaning they've recorded "10-baggers...
Source: SeekingAlpha
Date: November, 07 2018 03:12
Big Biotech May Be After These Technologies
HENDERSON, NV / ACCESSWIRE / November 6, 2018 / Big biotech stock buybacks "have destroyed more than $12 billion in value, and generated no positive return in total, at least as a portfolio investment," Leerink analyst Geoffry Porges recently said in a Marketwatch report. Big biotech has sp...
Source: ACCESSWIRE IA
Date: November, 06 2018 10:30
Pacific Biosciences Bows Out Gracefully
After many frustrating years of commercial execution lagging the potential of the technology, Pacific Biosciences ( PACB ) (“PacBio”) investors have a reason to be a little more cheerful this Friday. After the close on Thursday, the company and Illumina ( ILMN ) announced tha...
Source: SeekingAlpha
Date: November, 02 2018 15:34
Healthcare and Tech top list of midday movers (11/02/2018)
More news on: Pacific Biosciences of California, Emerge Energy Services LP, VivoPower International PLC, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: November, 02 2018 12:47
Surge In Healthcare Growth Sees Rally In These 3 Stocks On Friday
CORAL GABLES, FL / ACCESSWIRE / November 2, 2018 / Over the last few days, prices of the iShares Nasdaq Biotech ETF (IBB) as well as the SPDR Healthcare ETF (XLV) have recovered from previous lows this week. The healthcare sector is often regarded as a hedge from regular market forces. Re...
Source: ACCESSWIRE IA
Date: November, 02 2018 10:30
SBUX, SLS, EXEL among premarket's big gainers
Pacific Biosciences of California (NASDAQ: PACB ) +68%  on Q3 result . More news on: Pacific Biosciences of California, China Internet Nationwide Financial Services Inc., Exelixis, Inc., Stocks on the move, , Top stock market news, Read more ...
Source: SeekingAlpha
Date: November, 02 2018 09:18
Pacific Biosciences of California misses by $0.04, misses on revenue
Pacific Biosciences of California (NASDAQ: PACB ): Q3 GAAP EPS of -$0.19 misses by $0.04 . Revenue of $18.2M (-22.6% Y/Y) misses by $3.93M . Press Release More news on: Pacific Biosciences of California, Earnings news and commentary, Healthcare stocks news,
Source: SeekingAlpha
Date: November, 01 2018 16:23
Pacific Biosciences of California, Inc. Announces Third Quarter 2018 Financial Results
MENLO PARK, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its third quarter ended September 30, 2018. Total revenue for the third quarter of 2018 was $18.2 million, compared to $23.5 million for the ...
Source: GlobeNewswire
Date: November, 01 2018 16:15
Illumina to acquire Pacific Biosciences for $1.2B
Illumina (NASDAQ: ILMN ) has agreed to acquire Pacific Biosciences (NASDAQ: PACB ) for $8/share in cash, valuing the transaction at ~$1.2B. More news on: Illumina, Inc., Pacific Biosciences of California, Healthcare stocks news, Merger & acquisition news, Stocks on the move, Read...
Source: SeekingAlpha
Date: November, 01 2018 16:06

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-107.557.527.567.484,586,731
2018-12-077.647.537.6757.504,078,237
2018-12-067.657.707.707.535,399,421
2018-12-047.707.687.747.642,041,535
2018-12-037.827.707.827.6853,194,053

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-10405,187952,10342.5571Short
2018-12-07675,6761,061,66163.6433Short
2018-12-06554,7191,328,23141.7637Short
2018-12-04205,752501,71441.0098Short
2018-12-03350,708843,50141.5777Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on PACB.


About Pacific Biosciences of California, Inc. (NASDAQ: PACB)

Logo for Pacific Biosciences of California, Inc. (NASDAQ: PACB)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: PACB)

      Prospectus filed under Rule 424(b)(5)
      Filing Type: 424B5Filing Source: edgar
      Filing Date: September, 12 2018
      Prospectus filed under Rule 424(b)(5)
      Filing Type: 424B5Filing Source: edgar
      Filing Date: September, 10 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: September, 10 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: August, 03 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: August, 02 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: July, 31 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: July, 31 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 23 2018
      Specialized Disclosure Report
      Filing Type: SDFiling Source: edgar
      Filing Date: May, 18 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 08 2018

       

       


      Daily Technical Chart for (NASDAQ: PACB)

      Daily Technical Chart for (NASDAQ: PACB)


      Stay tuned for daily updates and more on (NASDAQ: PACB)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: PACB)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in PACB is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of PACB and does not buy, sell, or trade any shares of PACB. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/